Related Experiment Video
Updated: Jan 17, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
JNK kinase regulates phosphorylation of HCoV-229E nucleocapsid protein
Yannick Brüggemann1, Toni Luise Meister2,3,4,5, Natalie Heinen2
1Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany. yannick.brueggemann@ruhr-uni-bochum.de.
Abstract:
Identifying common host factors essential for the replication cycles of human coronaviruses (HCoV) could help uncover potential therapeutic targets. Mitogen-activated protein kinases (MAPKs) regulate critical cellular signaling pathways. Among them, c-Jun N-terminal kinases (JNK) are activated in response to diverse environmental stresses, including viral infections. However, the relevance of the JNK pathway for host responses and replication of HCoV infections has remained elusive. Using live-cell microscopy, quantitative immunofluorescence and immunoblotting, we found that JNK is specifically activated in cells infected with HCoV-229E and plays a crucial role in mediating the phosphorylation of the viral nucleocapsid (N) protein, an essential step required during the viral replication cycle. Consequently, pharmacological inhibition of JNK kinase activity impeded HCoV-229E as well as SARS-CoV-2 infection. Given the conservation of phosphorylation sites within the nucleocapsid protein across coronaviruses, inhibitors targeting these N protein kinases, such as JNK, may hold therapeutic promise as broad-spectrum CoV antivirals.
Insights
The c-Jun N-terminal kinase (JNK) pathway is crucial for human coronavirus (HCoV) replication. Inhibiting JNK effectively blocks HCoV-229E and SARS-CoV-2, suggesting JNK inhibitors as potential broad-spectrum antivirals.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Human coronaviruses (HCoV) pose significant health challenges, necessitating the identification of host factors for therapeutic targeting.
- Mitogen-activated protein kinases (MAPKs), particularly c-Jun N-terminal kinases (JNK), are involved in cellular stress responses, but their role in HCoV replication is not well understood.
Purpose of the Study:
- To investigate the role of the JNK signaling pathway in the replication cycle of human coronaviruses.
- To determine if JNK pathway activation is essential for HCoV replication and if it represents a viable therapeutic target.
Main Methods:
- Live-cell microscopy
- Quantitative immunofluorescence
- Immunoblotting
- Pharmacological inhibition of JNK kinase activity
Main Results:
- JNK signaling is specifically activated during HCoV-229E infection.
- JNK mediates the phosphorylation of the viral nucleocapsid (N) protein, a critical step in viral replication.
- Inhibition of JNK kinase activity significantly reduced HCoV-229E and SARS-CoV-2 replication.
Conclusions:
- The JNK pathway is essential for HCoV replication, highlighting its role in host-pathogen interactions.
- Targeting JNK kinase activity with pharmacological inhibitors shows promise as a broad-spectrum antiviral strategy against coronaviruses, including SARS-CoV-2.
More Related Videos
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Covalently Linked Protein Regulators
Protein Kinases and Phosphatases

